Mannkind Corporation (MNKD) 0.73 $MNKD
Securities Class Action Against MannKind Dismissed
GlobeNewswire - Thu Aug 25, 8:00AM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced that the United States District Court for the Central District of California has dismissed the class action that was pending against MannKind Corporation and two of its executives. The Court granted the defendants' motion to dismiss the plaintiffs' amended class action complaint without leave to amend, thereby closing the case. The plaintiffs can appeal the decision within 30 days.
MNKD: 0.73 (-0.07)
Research Report on Biotech Equities -- Celgene, Sarepta Therapeutics, MannKind, and Opko Health
PR Newswire - Wed Aug 24, 6:35AM CDT
Stock-Callers.com has on its radar four Biotech stocks, namely: Celgene Corp. (NASDAQ: CELG), Sarepta Therapeutics Inc. (NASDAQ: SRPT), MannKind Corp. (NASDAQ: MNKD), and Opko Health Inc. (NASDAQ: OPK). According to Transparency Market Research, the global white biotechnology market will grow at a CAGR of 4.5% over the period between 2016 and 2024. White biotechnology, or industrial biotechnology, comprises all the biotechnology uses related to industrial processes. Learn more about these stocks by accessing their free research reports at:
OPK: 9.29 (+0.19), SRPT: 26.56 (+0.49), MNKD: 0.73 (-0.07), CELG: 106.37 (-0.37), CELGZ: 1.13 (-0.03)
MannKind Corporation Reports 2016 Second Quarter Financial Results
GlobeNewswire - Mon Aug 08, 3:00PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today reported financial results for the second quarter and the six months ended June 30, 2016.
MNKD: 0.73 (-0.07)
MannKind Corporation to Hold 2016 Second Quarter Financial Results Conference Call on August 8, 2016
GlobeNewswire - Mon Aug 01, 4:00PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) will release its 2016 second quarter financial results on Monday, August 8, 2016 and its management will host a conference call to discuss the second quarter financial results and other Company developments at 5:00 PM (Eastern Time) on August 8, 2016.
MNKD: 0.73 (-0.07)
Mannkind Assumes Responsibility for Distribution of Afrezza(R) and Launches Patient Reimbursement and Adherence Support Programs
GlobeNewswire - Mon Aug 01, 8:00AM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced it is now distributing MannKind-branded Afrezza (insulin human) Inhalation Powder directly to major wholesalers and that Afrezza is available by prescription from retail pharmacies nationwide. The MannKind-branded product is associated with new National Drug Code (NDC) numbers, as noted in the table below. With distribution channels now stocked, the Company announced several key programs to promote access, adoption and adherence to Afrezza therapy.
MNKD: 0.73 (-0.07)
MannKind Announces Collaboration with JDRF
GlobeNewswire - Fri Jun 10, 8:00AM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that it has entered into a collaboration agreement with JDRF (formerly known as Juvenile Diabetes Research Foundation), the leading global organization funding type 1 diabetes research. The collaboration will combine JDRF's significant scientific and human resources with MannKind's active participation in the field of diabetes research and development in order to advance new treatments and therapies in areas of strategic alignment that can transform the lives of people with diabetes. A focus of the collaboration will be on the use of Afrezza(R), with its unique insulin delivery method, in the pediatric population.
MNKD: 0.73 (-0.07)
Pre-Market Technical Breakdown Highlights on Biotech Stocks
ACCESSWIRE - Wed Jun 01, 8:16AM CDT
LONDON, UK / ACCESSWIRE / June 1, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include Gilead Sciences, Baxalta, MannKind, and Sarepta Therapeutics.
GILD: 77.42 (-0.96), SRPT: 26.56 (+0.49), BXLT: 46.02 (-0.18), MNKD: 0.73 (-0.07)
MannKind Announces Pricing of Registered Direct Public Offering of Common Stock and Warrants
GlobeNewswire - Mon May 09, 5:24PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today announced the pricing of a registered direct public offering of up to 48,543,692 shares of common stock and warrants to purchase up to an aggregate of 48,543,692 shares of common stock to select institutional investors. Each share of common stock is being sold together with a warrant to purchase 0.75 of a share of common stock (A Warrants) and a warrant to purchase 0.25 of a share of common stock (B Warrants) for a combined purchase price of $1.03. The A Warrants will be exercisable at a price of $1.50 per share beginning upon issuance and will expire two years thereafter. The B Warrants will be exercisable at a price of $1.50 per share beginning in May 2017 and expire 18 months thereafter. The shares of common stock and the warrants will be immediately separable and will be issued separately. The offering is expected to close on or about May 12, 2016, subject to customary closing conditions.
MNKD: 0.73 (-0.07)
MannKind Corporation Reports 2016 First Quarter Financial Results
GlobeNewswire - Mon May 09, 3:00PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today reported financial results for the first quarter ended March 31, 2016.
MNKD: 0.73 (-0.07)
MannKind Corporation to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
GlobeNewswire - Thu May 05, 4:00PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that the Company will present at the Bank of America Merrill Lynch 2016 Health Care Conference on Thursday, May 12, 2016 at 8:00 AM (PDT) at the Encore at Wynn Hotel in Las Vegas, Nevada.
MNKD: 0.73 (-0.07)
MannKind Corporation to Hold 2016 First Quarter Financial Results Conference Call on May 9, 2016
GlobeNewswire - Mon May 02, 4:00PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) will release its 2016 first quarter financial results on Monday, May 9, 2016 and its management will host a conference call to discuss the first quarter financial results and other Company developments at 5:00 PM (Eastern Time) on May 9, 2016.
MNKD: 0.73 (-0.07)
Does Healthcare’s Past Predict its Future?
Michael Douglass and Kristine Harjes, The Motley Fool - Motley Fool - Sun May 01, 1:03PM CDT
It's time travel week at Industry Focus ! In this healthcare episode, Kristine Harjes brings on former host Michael Douglass to talk about how the healthcare industry has changed (and some areas it hasn't) since he left the show. Listen in to...
ANTM: 123.36 (-1.72), GILD: 77.42 (-0.96), MNKD: 0.73 (-0.07)
The Next Stock Warren Buffett May Sell
Matthew Frankel, Sean Williams, and Brian Feroldi, The Motley Fool - Motley Fool - Sun May 01, 12:09PM CDT
What stocks Warren Buffett is buying is a closely followed story by many investors. However, since he's known as a buy-and-hold investor, it's less common to hear someone ask "What is Buffett selling ?" However, Buffett does unload stocks from time...
T: 40.96 (+0.08), GM: 31.80 (-0.12), SNY: 38.41 (-0.06), MNKD: 0.73 (-0.07)
Ignore MannKind Corp.: Here Are 3 Better Stocks
Cory Renauer, The Motley Fool - Motley Fool - Mon Apr 25, 9:01AM CDT
Image source: MannKind Corp. I've never seen an independent auditor report so grim as MannKind 's latest. The maker of inhalable insulin Afrezza has been in dire shape ever since marketing partner Sanofi ended their collaboration agreement,...
ZIOP: 4.99 (-0.08), CLDX: 3.36 (+0.04), XON: 25.29 (+0.05), MNKD: 0.73 (-0.07)
3 Healthcare Stocks We Won't Buy
Brian Feroldi, Keith Speights, and Cory Renauer, The Motley Fool - Motley Fool - Tue Apr 19, 3:22PM CDT
PHOTO CREDIT: BRYAN ROSENGRANT ON FLICKR. Did you know that roughly 10,000 baby boomers will turn 65 every day for the next 13 years? It's true, and that fact should be a boon to the healthcare sector, in general, as spending on staying healthy...
VRX: 29.12 (+0.09), LLY: 77.23 (-0.52), MNKD: 0.73 (-0.07)
Analyst Call Rescheduled to April 26, 2016
GlobeNewswire - Tue Apr 19, 12:26PM CDT
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) has postponed its analyst call scheduled for today, April 19, 2016, due to the unavailability of its Chief Executive Officer, Matthew J. Pfeffer. Mr. Pfeffer was diagnosed overnight with a retinal detachment, and is undergoing emergency surgery this morning to correct the condition.
MNKD: 0.73 (-0.07)
MannKind Expands Commercial Capabilities With Two New Hires
GlobeNewswire - Tue Apr 19, 8:00AM CDT
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced two senior appointments to its commercial organization. Joining the Company are Joseph Saldanha as Vice President of Marketing and Agustin (Tino) Quintero as Vice President of Market Value, Access and Trade. Both will report to Michael Castagna, MannKind's Chief Commercial Officer.
MNKD: 0.73 (-0.07)
Better Buy: MannKind Corporation vs. Sanofi
Brian Feroldi, The Motley Fool - Motley Fool - Thu Apr 14, 9:03AM CDT
Image source: Bill Brooks via Flickr Creative Commons. It's been a rough couple of years to be an investor in both Sanofi and MannKind . Both companies have faced their own set of unique challenges that have caused their shares to drastically...
SNY: 38.41 (-0.06), MNKD: 0.73 (-0.07), REGN: 393.40 (+0.85)
Why MannKind Corporation Shares Are Soaring 14% Today
Todd Campbell, The Motley Fool - Motley Fool - Tue Apr 12, 11:44AM CDT
IMAGE SOURCE: MANNKIND CORPORATION. What: A week before its planned investor conference on April 19 to explain its commercialization strategy for Afrezza, shares of MannKind Corporation are skyrocketing 13.7% at 12:00 p.m. ET today. So...
SNY: 38.41 (-0.06), MNKD: 0.73 (-0.07)
Hertz Global Holdings Inc Slumps and MannKind Corporation Soars as Stocks Drop
Demitrios Kalogeropoulos, The Motley Fool - Motley Fool - Mon Apr 11, 4:35PM CDT
Stocks stumbled into the start of earnings season on Monday, with early gains evaporating by the end of the trading session. Despite opening higher by almost 1%, the Dow Jones Industrial Average had lost 21 points, or 0.1%, by the closing bell....
HTZ: 49.23 (-0.03), SNY: 38.41 (-0.06), MNKD: 0.73 (-0.07)
Securities Class Action Against MannKind Dismissed
GlobeNewswire - Thu Aug 25, 8:00AM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced that the United States District Court for the Central District of California has dismissed the class action that was pending against MannKind Corporation and two of its executives. The Court granted the defendants' motion to dismiss the plaintiffs' amended class action complaint without leave to amend, thereby closing the case. The plaintiffs can appeal the decision within 30 days.
MNKD: 0.73 (-0.07)
Research Report on Biotech Equities -- Celgene, Sarepta Therapeutics, MannKind, and Opko Health
PR Newswire - Wed Aug 24, 6:35AM CDT
Stock-Callers.com has on its radar four Biotech stocks, namely: Celgene Corp. (NASDAQ: CELG), Sarepta Therapeutics Inc. (NASDAQ: SRPT), MannKind Corp. (NASDAQ: MNKD), and Opko Health Inc. (NASDAQ: OPK). According to Transparency Market Research, the global white biotechnology market will grow at a CAGR of 4.5% over the period between 2016 and 2024. White biotechnology, or industrial biotechnology, comprises all the biotechnology uses related to industrial processes. Learn more about these stocks by accessing their free research reports at:
OPK: 9.29 (+0.19), SRPT: 26.56 (+0.49), MNKD: 0.73 (-0.07), CELG: 106.37 (-0.37), CELGZ: 1.13 (-0.03)
MannKind Corporation Reports 2016 Second Quarter Financial Results
GlobeNewswire - Mon Aug 08, 3:00PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today reported financial results for the second quarter and the six months ended June 30, 2016.
MNKD: 0.73 (-0.07)
MannKind Corporation to Hold 2016 Second Quarter Financial Results Conference Call on August 8, 2016
GlobeNewswire - Mon Aug 01, 4:00PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) will release its 2016 second quarter financial results on Monday, August 8, 2016 and its management will host a conference call to discuss the second quarter financial results and other Company developments at 5:00 PM (Eastern Time) on August 8, 2016.
MNKD: 0.73 (-0.07)
Mannkind Assumes Responsibility for Distribution of Afrezza(R) and Launches Patient Reimbursement and Adherence Support Programs
GlobeNewswire - Mon Aug 01, 8:00AM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced it is now distributing MannKind-branded Afrezza (insulin human) Inhalation Powder directly to major wholesalers and that Afrezza is available by prescription from retail pharmacies nationwide. The MannKind-branded product is associated with new National Drug Code (NDC) numbers, as noted in the table below. With distribution channels now stocked, the Company announced several key programs to promote access, adoption and adherence to Afrezza therapy.
MNKD: 0.73 (-0.07)
MannKind Announces Collaboration with JDRF
GlobeNewswire - Fri Jun 10, 8:00AM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that it has entered into a collaboration agreement with JDRF (formerly known as Juvenile Diabetes Research Foundation), the leading global organization funding type 1 diabetes research. The collaboration will combine JDRF's significant scientific and human resources with MannKind's active participation in the field of diabetes research and development in order to advance new treatments and therapies in areas of strategic alignment that can transform the lives of people with diabetes. A focus of the collaboration will be on the use of Afrezza(R), with its unique insulin delivery method, in the pediatric population.
MNKD: 0.73 (-0.07)
Pre-Market Technical Breakdown Highlights on Biotech Stocks
ACCESSWIRE - Wed Jun 01, 8:16AM CDT
LONDON, UK / ACCESSWIRE / June 1, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include Gilead Sciences, Baxalta, MannKind, and Sarepta Therapeutics.
GILD: 77.42 (-0.96), SRPT: 26.56 (+0.49), BXLT: 46.02 (-0.18), MNKD: 0.73 (-0.07)
MannKind Announces Pricing of Registered Direct Public Offering of Common Stock and Warrants
GlobeNewswire - Mon May 09, 5:24PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today announced the pricing of a registered direct public offering of up to 48,543,692 shares of common stock and warrants to purchase up to an aggregate of 48,543,692 shares of common stock to select institutional investors. Each share of common stock is being sold together with a warrant to purchase 0.75 of a share of common stock (A Warrants) and a warrant to purchase 0.25 of a share of common stock (B Warrants) for a combined purchase price of $1.03. The A Warrants will be exercisable at a price of $1.50 per share beginning upon issuance and will expire two years thereafter. The B Warrants will be exercisable at a price of $1.50 per share beginning in May 2017 and expire 18 months thereafter. The shares of common stock and the warrants will be immediately separable and will be issued separately. The offering is expected to close on or about May 12, 2016, subject to customary closing conditions.
MNKD: 0.73 (-0.07)
MannKind Corporation Reports 2016 First Quarter Financial Results
GlobeNewswire - Mon May 09, 3:00PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) today reported financial results for the first quarter ended March 31, 2016.
MNKD: 0.73 (-0.07)
MannKind Corporation to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
GlobeNewswire - Thu May 05, 4:00PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced today that the Company will present at the Bank of America Merrill Lynch 2016 Health Care Conference on Thursday, May 12, 2016 at 8:00 AM (PDT) at the Encore at Wynn Hotel in Las Vegas, Nevada.
MNKD: 0.73 (-0.07)
MannKind Corporation to Hold 2016 First Quarter Financial Results Conference Call on May 9, 2016
GlobeNewswire - Mon May 02, 4:00PM CDT
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) will release its 2016 first quarter financial results on Monday, May 9, 2016 and its management will host a conference call to discuss the first quarter financial results and other Company developments at 5:00 PM (Eastern Time) on May 9, 2016.
MNKD: 0.73 (-0.07)
Does Healthcare’s Past Predict its Future?
Michael Douglass and Kristine Harjes, The Motley Fool - Motley Fool - Sun May 01, 1:03PM CDT
It's time travel week at Industry Focus ! In this healthcare episode, Kristine Harjes brings on former host Michael Douglass to talk about how the healthcare industry has changed (and some areas it hasn't) since he left the show. Listen in to...
ANTM: 123.36 (-1.72), GILD: 77.42 (-0.96), MNKD: 0.73 (-0.07)
The Next Stock Warren Buffett May Sell
Matthew Frankel, Sean Williams, and Brian Feroldi, The Motley Fool - Motley Fool - Sun May 01, 12:09PM CDT
What stocks Warren Buffett is buying is a closely followed story by many investors. However, since he's known as a buy-and-hold investor, it's less common to hear someone ask "What is Buffett selling ?" However, Buffett does unload stocks from time...
T: 40.96 (+0.08), GM: 31.80 (-0.12), SNY: 38.41 (-0.06), MNKD: 0.73 (-0.07)
Ignore MannKind Corp.: Here Are 3 Better Stocks
Cory Renauer, The Motley Fool - Motley Fool - Mon Apr 25, 9:01AM CDT
Image source: MannKind Corp. I've never seen an independent auditor report so grim as MannKind 's latest. The maker of inhalable insulin Afrezza has been in dire shape ever since marketing partner Sanofi ended their collaboration agreement,...
ZIOP: 4.99 (-0.08), CLDX: 3.36 (+0.04), XON: 25.29 (+0.05), MNKD: 0.73 (-0.07)
3 Healthcare Stocks We Won't Buy
Brian Feroldi, Keith Speights, and Cory Renauer, The Motley Fool - Motley Fool - Tue Apr 19, 3:22PM CDT
PHOTO CREDIT: BRYAN ROSENGRANT ON FLICKR. Did you know that roughly 10,000 baby boomers will turn 65 every day for the next 13 years? It's true, and that fact should be a boon to the healthcare sector, in general, as spending on staying healthy...
VRX: 29.12 (+0.09), LLY: 77.23 (-0.52), MNKD: 0.73 (-0.07)
Analyst Call Rescheduled to April 26, 2016
GlobeNewswire - Tue Apr 19, 12:26PM CDT
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) has postponed its analyst call scheduled for today, April 19, 2016, due to the unavailability of its Chief Executive Officer, Matthew J. Pfeffer. Mr. Pfeffer was diagnosed overnight with a retinal detachment, and is undergoing emergency surgery this morning to correct the condition.
MNKD: 0.73 (-0.07)
MannKind Expands Commercial Capabilities With Two New Hires
GlobeNewswire - Tue Apr 19, 8:00AM CDT
MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced two senior appointments to its commercial organization. Joining the Company are Joseph Saldanha as Vice President of Marketing and Agustin (Tino) Quintero as Vice President of Market Value, Access and Trade. Both will report to Michael Castagna, MannKind's Chief Commercial Officer.
MNKD: 0.73 (-0.07)
Better Buy: MannKind Corporation vs. Sanofi
Brian Feroldi, The Motley Fool - Motley Fool - Thu Apr 14, 9:03AM CDT
Image source: Bill Brooks via Flickr Creative Commons. It's been a rough couple of years to be an investor in both Sanofi and MannKind . Both companies have faced their own set of unique challenges that have caused their shares to drastically...
SNY: 38.41 (-0.06), MNKD: 0.73 (-0.07), REGN: 393.40 (+0.85)
Why MannKind Corporation Shares Are Soaring 14% Today
Todd Campbell, The Motley Fool - Motley Fool - Tue Apr 12, 11:44AM CDT
IMAGE SOURCE: MANNKIND CORPORATION. What: A week before its planned investor conference on April 19 to explain its commercialization strategy for Afrezza, shares of MannKind Corporation are skyrocketing 13.7% at 12:00 p.m. ET today. So...
SNY: 38.41 (-0.06), MNKD: 0.73 (-0.07)
Hertz Global Holdings Inc Slumps and MannKind Corporation Soars as Stocks Drop
Demitrios Kalogeropoulos, The Motley Fool - Motley Fool - Mon Apr 11, 4:35PM CDT
Stocks stumbled into the start of earnings season on Monday, with early gains evaporating by the end of the trading session. Despite opening higher by almost 1%, the Dow Jones Industrial Average had lost 21 points, or 0.1%, by the closing bell....
HTZ: 49.23 (-0.03), SNY: 38.41 (-0.06), MNKD: 0.73 (-0.07)
